📢We’re ready— #Targets25 kicked off!

www.aacr.org/meeting/aacr...

Our lab will share new work on epigenetic targets in leukemia 🧬🎯.

Join us Sat, Oct 25 in Plenary Session 6 where invited speaker Irmela Jeremias highlights how PDX models reveal actionable targets.

#Leukemia #Epigenetics

🎉 Excited to share our collaborative research efforts with the Carell lab at ESH AML 2025 starting today! Visit our poster "A novel Decitabine analogue with enhanced anti-leukemia activity and reduced toxicity in vivo".

www.esh.org/conference/7...

#ESHAML2025 #AML #PDX #TranslationalMedicine

🚨 New preprint alert! 🚨

We just posted our latest manuscript on patient-derived xenograft (PDX) models in acute myeloid leukemia (AML):

📝 "A platform of robust patient-derived leukemia models covering subgroups for which no cell lines exist"

www.biorxiv.org/content/10.1...

Why this matters ⬇️

🚀 The 12th International Heidelberg Symposium on Stem Cells and Cancer – SCC2025 kicks off today!

The @jeremiaslab.bsky.social is thrilled to join leading experts to explore groundbreaking advances in the cancer stem cell field and spark new discussions.

stem-cells-cancer.de/event/scc2025/

Our recent lab trip to Oberammergau was the perfect mix of adventure, fresh mountain air, and team spirit 🌲💧. Exploring together and sharing new experiences outside the lab made this a truly memorable summer day! #acute#leukemia#research

🔬 @jeremiaslab.bsky.social is excited to attend the XXXVI. Kind-Philipp-Meeting! Irmela, @sercoz.bsky.social and Dhruv Mehra are on their way to Wilsede.

www.kind-philipp-meeting.de

Looking forward to an engaging program and to meeting experts and early career researchers in paediatric cancer!

📢 We’re heading to Dublin!

Irmela Jeremias will be attending the 4th Translational Research Conference: Acute Lymphoblastic Leukaemia (ALL).

We’re excited to share our latest research during the poster session.

#ESHALL2025 #LeukemiaResearch #CRISPR #PDXmodels #TranslationalResearch

A PhD position is open in my group here in Heidelberg. We'll use cool primary cell models of osteosarcoma and genetic screens to understand and overcome mechanisms of clinically acquired drug resistance. It'll be a blast!

karriere.klinikum.uni-heidelberg.de/index.php?ac...

🔬 Excited to share that Irmela Jeremias will be attending the 14th I-BFM Biennial Childhood Leukemia and Lymphoma Symposium this weekend in Budapest!

clls-symposium.org

🌸Science in full blossom 🌸

Last week the @jeremiaslab.bsky.social had a productive get-together culminating in fresh ideas, collaborative energy, team spirit and a picture under the beautiful cherry blossoms. Nothing like spring to inspire new discoveries! #Science#AcuteLeukemia

Great and incredibly important initiative! Thank you for organizing this event!

🎉 We’re excited to share our latest research on FLT3-targeted antibody-drug conjugates (ADCs) as a promising strategy to eliminate leukemic stem cells in AML! 🚀🔬Many thanks to all involved in this great BMBF-funded project #leukemia #PDXmodels

📖Read more here: www.nature.com/articles/s41...

We wrapped up an amazing and successful year in the
@jeremiaslab.bsky.social with a wonderful party, delicious food, and great company. Wishing everyone a joyful holiday season and a fantastic start to 2025! 🎉🍽️✨